$82.5 Million is the total value of Healthcare Value Capital, LLC's 26 reported holdings in Q2 2016. The portfolio turnover from Q1 2016 to Q2 2016 was 33.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ANIP | Sell | ANI PHARMACEUTICALS INC | $19,258,000 | +44.8% | 345,000 | -12.7% | 23.35% | +19.5% |
| SPY | Buy | SPDR S&P 500 ETF TRput | $15,711,000 | +205.8% | 75,000 | +200.0% | 19.05% | +152.4% |
| DEPO | DEPOMED INC | $6,867,000 | +40.8% | 350,000 | 0.0% | 8.32% | +16.2% | |
| PFE | PFIZER INC | $6,162,000 | +18.8% | 175,000 | 0.0% | 7.47% | -2.0% | |
| DGX | QUEST DIAGNOSTICS INC | $5,390,000 | +13.9% | 66,208 | 0.0% | 6.53% | -6.0% | |
| CRY | CRYOLIFE INC | $4,724,000 | +9.9% | 400,000 | 0.0% | 5.73% | -9.3% | |
| AMRI | Sell | ALBANY MOLECULAR RESH INC | $4,064,000 | -34.0% | 302,400 | -24.9% | 4.93% | -45.5% |
| QLTI | QLT INC | $3,063,000 | -28.7% | 2,157,200 | 0.0% | 3.71% | -41.1% | |
| ANIP | New | ANI PHARMACEUTICALS INCput | $2,791,000 | – | 50,000 | +100.0% | 3.38% | – |
| AMAG | New | AMAG PHARMACEUTICALS INCput | $2,512,000 | – | 105,000 | +100.0% | 3.04% | – |
| DEPO | DEPOMED INCcall | $1,962,000 | +40.8% | 100,000 | 0.0% | 2.38% | +16.2% | |
| ARLZ | Buy | ARALEZ PHARMACEUTICALS INC | $1,898,000 | +434.6% | 575,000 | +475.0% | 2.30% | +341.7% |
| TWM | PROSHARES TRcall | $1,742,000 | -10.2% | 50,000 | 0.0% | 2.11% | -25.8% | |
| CYTK | CYTOKINETICS INC | $949,000 | +34.6% | 100,000 | 0.0% | 1.15% | +11.0% | |
| VIXY | New | PROSHARES TR IIcall | $916,000 | – | 100,000 | +100.0% | 1.11% | – |
| TWM | PROSHARES TRultsht russ2000 | $871,000 | -10.1% | 25,000 | 0.0% | 1.06% | -25.8% | |
| SGNT | SAGENT PHARMACEUTICALS INC | $749,000 | +23.0% | 50,000 | 0.0% | 0.91% | +1.5% | |
| AMRI | ALBANY MOLECULAR RESH INCcall | $672,000 | -12.2% | 50,000 | 0.0% | 0.82% | -27.5% | |
| CRY | CRYOLIFE INCcall | $591,000 | +9.9% | 50,000 | 0.0% | 0.72% | -9.4% | |
| SGNT | SAGENT PHARMACEUTICALS INCcall | $524,000 | +23.0% | 35,000 | 0.0% | 0.64% | +1.4% | |
| ZGNX | ZOGENIX INC | $256,000 | -12.9% | 31,850 | 0.0% | 0.31% | -28.2% | |
| ARLZ | Sell | ARALEZ PHARMACEUTICALS INCcall | $248,000 | -60.1% | 75,000 | -57.1% | 0.30% | -67.0% |
| APRI | APRICUS BIOSCIENCES INC | $176,000 | -31.2% | 440,000 | 0.0% | 0.21% | -43.4% | |
| FCSC | FIBROCELL SCIENCE INC | $170,000 | -53.9% | 147,769 | 0.0% | 0.21% | -62.0% | |
| QLTI | QLT INCcall | $142,000 | -3.4% | 100,000 | 0.0% | 0.17% | -20.4% | |
| SNSS | SUNESIS PHARMACEUTICALS INCcall | $82,000 | +1.2% | 150,000 | 0.0% | 0.10% | -16.8% | |
| SRNE | Exit | SORRENTO THERAPEUTICS INC | $0 | – | -50,000 | -100.0% | -0.40% | – |
| ACAD | Exit | ACADIA PHARMACEUTICALS INCput | $0 | – | -20,000 | -100.0% | -0.82% | – |
| LCI | Exit | LANNET INCcall | $0 | – | -50,000 | -100.0% | -1.32% | – |
| EGRX | Exit | EAGLE PHARMACEUTICALS INCcall | $0 | – | -50,000 | -100.0% | -2.98% | – |
| GSK | Exit | GLAXOSMITHKLINE PLCcall | $0 | – | -50,000 | -100.0% | -2.98% | – |
| BIS | Exit | PROSHARES TRcall | $0 | – | -50,000 | -100.0% | -3.20% | – |
| AGN | Exit | ALLERGAN PLC | $0 | – | -10,000 | -100.0% | -3.94% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2016-08-15
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| GILEAD SCIENCES INC | 20 | Q3 2021 | 31.3% |
| GLAXOSMITHKLINE PLC | 20 | Q3 2021 | 16.1% |
| PFIZER INC | 19 | Q3 2021 | 17.9% |
| TYME TECHNOLOGIES INC | 17 | Q3 2021 | 40.3% |
| ASTRAZENECA PLC | 14 | Q3 2021 | 12.9% |
| QUEST DIAGNOSTICS INC | 14 | Q3 2016 | 9.5% |
| CRYOLIFE INC | 13 | Q1 2017 | 6.6% |
| ANTARES PHARMA INC | 13 | Q3 2021 | 6.7% |
| AMARIN CORP PLC | 13 | Q3 2021 | 4.9% |
| CYTOKINETICS INC | 13 | Q3 2016 | 1.7% |
View Healthcare Value Capital, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| NOVELION THERAPEUTICS INC. | September 20, 2019 | 1,400,000 | 7.4% |
View Healthcare Value Capital, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2021-11-15 |
| 13F-HR | 2021-08-16 |
| 13F-HR | 2021-05-17 |
| 13F-HR | 2021-02-16 |
| 13F-HR | 2020-11-16 |
| 13F-HR | 2020-08-14 |
| 13F-HR | 2020-05-15 |
| 13F-HR | 2020-02-14 |
| 13F-HR | 2019-11-14 |
| SC 13D/A | 2019-09-20 |
View Healthcare Value Capital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.